Phase IV clinical trial for alectinib as first-line treatment of advanced non-small cell lung cancer with positive ALK gene.

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2020
This article has no abstract
Epistemonikos ID: 10a988edd6b46ae161943b37f18c4c7d78f81ff1
First added on: Apr 07, 2025